Business Standard

Top headlines: Aurobindo Pharma to sell Natrol; Navratri drives car sales

From Aurobindo Pharma's plans to sell US-based Natrol to Kishore Biyani looking for mutual settlement, here are top headlines this morning

maruti suzuki, maruti, cars, car sale, car demand, auto demand, car sales
Premium

Car deliveries during the nine-day period saw sharp year-on-year (YoY) double-digit increase.

BS Web Team New Delhi
Aurobindo Pharma to sell US-based Natrol for about Rs 4,048 crore

Hyderabad-based Aurobindo Pharma has reached a definitive agreement to sell its US subsidiary Natrol LLC to private equity firm New Mountain Capital and its affiliate Jarrow Formulas in an all-cash transaction valued at $550 mn (about Rs 4,048 crore). This would make Aurobindo a zero-debt company and also help it repay loans, analysts said. Read More

Sea change in customs clearance as govt addresses complaints over delays

In a significant relief for importers, customs clearance saw a dramatic improvement over the weekend with about three-fourths of sea

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in